Shares of LightPath Technologies cratered for the second straight session, dropping 10.3% to $10.07 on Monday after tumbling 18.6% on Friday, as the U.S. Army threw a wrench into what investors had treated as a near-certain revenue pipeline. The combined two-day wipeout has erased roughly a quarter of the stock's value and forces a hard reassessment of how much of the company's future was already priced in.

  • The Army Wants More Options, and That Changes the Timeline. The Army put out a contracting notice for what it calls an Alternate Interceptor Demonstration , seeking "to identify additional potential sources" for its next-generation short-range air-defense missile.

The service has funded two competing designs from Lockheed Martin and Raytheon since 2023, aiming to buy 11,000 missiles starting in fiscal year 2028. Opening the field to new entrants means a demonstration round now scheduled for spring 2027 — adding uncertainty to a production decision that investors had viewed as imminent.

  • LightPath's Biggest Bet Runs Through Lockheed. LightPath formed a partnership with Lockheed Martin in 2023 to supply an advanced thermal camera system to act as the seeker head for the missile.

Management has said each missile could mean $5,000 to $10,000 in revenue for LightPath, with volumes potentially reaching 10,000 missiles a year at full-rate production.

If selected, that could represent $50 million to $100 million in annual revenue — transformative for a company that generated just $37.2 million in fiscal 2025 revenue. But none of it materializes unless Lockheed wins.

  • Analysts Trimmed Targets but Didn't Bail Out. Canaccord lowered its price target to $15.50 from $16.50 while maintaining a Buy rating.

The firm noted that any competing design will be behind, considering Lockheed and Raytheon each have roughly three years of design, qualification, and testing work already completed.

Piper Sandler separately carries an Overweight rating with a $15 target. Even the reduced consensus implies about 55% upside from today's price — but that gap itself signals how much risk the Street is pricing in.

  • A Macro Headwind Makes the Selloff Worse. Broader industrial stocks are under pressure, with the XLI index down 2.01%, amid geopolitical tensions, higher oil prices, and hawkish Federal Reserve signals. For a micro-cap defense supplier already reeling from program uncertainty, the risk-off mood amplifies every negative headline.

The core question is binary: does Lockheed still win this contract? The Army expects to select one company in fiscal year 2028. Until then, LightPath's valuation is a leveraged bet on a Pentagon decision it cannot control.